|
covid-19 |
13 |
|
chinese |
11 |
|
psychosis |
10 |
|
ideas of reference |
9 |
|
life events |
9 |
|
psychotic-like experiences |
9 |
|
rumination |
9 |
|
traumatic events |
9 |
|
depressive symptoms |
8 |
|
mass screening |
8 |
|
ptsd symptoms |
8 |
|
trauma exposure |
8 |
|
intervention |
7 |
|
meta-analysis |
7 |
|
mindfulness |
7 |
|
negative symptoms |
7 |
|
amotivation |
6 |
|
antipsychotics |
6 |
|
clinical predictors |
6 |
|
clozapine-resistant schizophrenia |
6 |
|
cognitive functions |
6 |
|
cognitive impairment |
6 |
|
depression |
6 |
|
discontinuation |
6 |
|
early intervention service |
6 |
|
effort discounting |
6 |
|
effort-based decision-making |
6 |
|
effort-cost computation |
6 |
|
first-episode psychosis |
6 |
|
global functioning |
6 |
|
guideline |
6 |
|
internal feed-forward |
6 |
|
long-term outcomes |
6 |
|
maintenance treatment |
6 |
|
motivational deficits |
6 |
|
passivity experiences |
6 |
|
recommendation |
6 |
|
remission |
6 |
|
schizophrenia |
6 |
|
self-monitoring |
6 |
|
subjective quality of life |
6 |
|
treatment |
6 |
|
treatment resistant schizophrenia |
6 |
|
adverse childhood experiences |
5 |
|
anticholinergic load |
5 |
|
child behavioral health |
5 |
|
cognitive function |
5 |
|
collective stressors |
5 |
|
company |
5 |
|
cotinine assay |
5 |
|
passive smoking |
5 |
|
salivary cotinine concentration |
5 |
|
secondhand smoke (shs) |
5 |
|
smoking cessation |
5 |
|
structural equation model |
5 |
|
voluntary |
5 |
|
workplace |
5 |
|
world assumptions |
5 |
|
youth mental health |
5 |
|
clinical high risk |
3 |
|
consortium |
3 |
|
early detection |
3 |
|
prediction |
3 |
|
prevention |
3 |
|
collective efficacy |
2 |
|
encouragement |
2 |
|
exercise |
2 |
|
hong kong |
2 |
|
physical activity |
2 |
|
preschool-age children |
2 |
|
role model |
2 |
|
safety |
2 |
|
scale validity |
2 |
|
screen time |
2 |
|
young children |
2 |
